SEC 13F Intelligence

Sv Health Investors, LLC / RGEN

Sv Health Investors, LLC’s Repligen Corp Position

Does Sv Health Investors, LLC own Repligen Corp (RGEN)? Not currently — the last reported position was 14.5K shares worth $4M in Q3 2021; the fund’s latest 13F (Q3 2022) no longer reports it.

Position Value
$4M
Q3 2021
Shares
14.5K
% of Portfolio
+2.06%
Quarters Held
1
position exited

Position History RGEN

Reported value by quarter
Q3 ’21: $4MQ3 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202114.5K$4M+2.06%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sv Health Investors, LLC’s full portfolio or all institutional holders of RGEN.